Michael Kors Holdings Ltd (KORS), Phillips 66 (PSX), Kinder Morgan Inc (KMI): These IPO Stocks Have Been Winners

AbbVie Inc (NYSE:ABBV), which only began trading early this year, is up more than 20% over its opening price. Recently split off from Abbott Labs, AbbVie Inc (NYSE:ABBV) focuses on pharmaceuticals, while Abbott focuses on medical, diagnostic, and nutritional products. In AbbVie’s recent second quarter, revenue rose 4.4%, while net income took a 16% hit, though its blockbuster drug Humira (the world’s biggest-selling prescription drug), which tackles arthritis and more, delivered well, with sales up 16%, to $2.6 billion for the quarter. (That’s a run rate of more than $10 billion annually!) Some worry about AbbVie Inc (NYSE:ABBV)’s debt load, though, and about its dependence on Humira for a big chunk of revenue, especially with Humira’s patent protection expiring in the near future. Bulls look to its pipeline for future growth. The stock yields about 3.7%.

The big picture
A well-chosen ETF can grant you instant diversification across any industry or group of companies — and make investing in and profiting from it that much easier.

The article These IPO Stocks Have Been Winners originally appeared on Fool.com and is written by Selena Maranjian.

Longtime Fool contributor Selena Maranjian, whom you can follow on Twitter, holds no position in any stocks mentioned. The Motley Fool recommends Coach, Fossil, and Kinder Morgan. The Motley Fool owns shares of Coach, Fossil, and Kinder Morgan.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.